These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26513309)

  • 1. Options to Promote Competitive Generics Markets in the United States.
    Wiske CP; Ogbechie OA; Schulman KA
    JAMA; 2015 Nov; 314(20):2129-30. PubMed ID: 26513309
    [No Abstract]   [Full Text] [Related]  

  • 2. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics".
    Zain S
    Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229
    [No Abstract]   [Full Text] [Related]  

  • 3. International experiences of promoting generics use and its implications to China.
    Sun J
    J Evid Based Med; 2013 May; 6(2):74-80. PubMed ID: 23829799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health plans keeping drug cost increases in check with programs that promote generics.
    Capitation Manag Rep; 2002 Jul; 9(7):101-3, 97. PubMed ID: 12164057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of being first: evidence from Canadian generic pharmaceuticals.
    Hollis A
    Health Econ; 2002 Dec; 11(8):723-34. PubMed ID: 12457372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 7. Price survey. Generic drug market heats up.
    Hosp Mater Manage; 2001 Mar; 26(3):1, 12-3. PubMed ID: 11975141
    [No Abstract]   [Full Text] [Related]  

  • 8. PBMs' rebate income threatened by lawsuits and move to generics.
    Sipkoff M
    Manag Care; 2008 Mar; 17(3):11-2. PubMed ID: 18447152
    [No Abstract]   [Full Text] [Related]  

  • 9. Generic Price Competition For Specialty Drugs: Too Little, Too Late?
    Cole AL; Dusetzina SB
    Health Aff (Millwood); 2018 May; 37(5):738-742. PubMed ID: 29733710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who's really raising drug prices?
    Zagorin A
    Time; 1999 Mar; 153(9):46-8. PubMed ID: 10346086
    [No Abstract]   [Full Text] [Related]  

  • 11. Valuable information regarding generic drugs. Cutting costs by going generic.
    J Am Vet Med Assoc; 2004 Oct; 225(8):1168. PubMed ID: 15521435
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic drugs get a life.
    Cole RT; Saputo D
    Mark Health Serv; 2003; 23(1):18-23. PubMed ID: 12645433
    [No Abstract]   [Full Text] [Related]  

  • 13. High Costs of FDA Approval for Formerly Unapproved Marketed Drugs.
    Hakim A; Gupta R; Ross JS
    JAMA; 2017 Dec; 318(22):2181-2182. PubMed ID: 29131905
    [No Abstract]   [Full Text] [Related]  

  • 14. [Discount for only one drug of the same group leads to impaired health care quality].
    Bergström R
    Lakartidningen; 2006 Feb 8-14; 103(6):387-8; discussion 388. PubMed ID: 16536044
    [No Abstract]   [Full Text] [Related]  

  • 15. Competition and the Reference Pricing Scheme for pharmaceuticals.
    Ghislandi S
    J Health Econ; 2011 Dec; 30(6):1137-49. PubMed ID: 21937137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indian generics companies go on spending spree.
    Jayaraman KS
    Nat Rev Drug Discov; 2005 Aug; 4(8):616-7. PubMed ID: 16106583
    [No Abstract]   [Full Text] [Related]  

  • 17. Strategic options for brand-name prescription drugs when patents expire.
    Mehta SC; Mehta SS
    Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encouraging the use of generic medicines: implications for transition economies.
    King DR; Kanavos P
    Croat Med J; 2002 Aug; 43(4):462-9. PubMed ID: 12187525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survey of pharmacists: impact of the generic drug scandal and implications for marketing generic drugs.
    Gupta PB
    Health Mark Q; 1996; 13(3):109-20. PubMed ID: 10158484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.